Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 3/20 | 0.51 |
| ▸ | IL6 | P05231 | 1/20 | 0.50 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 7/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.48 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4468017 | 0.94 | PRMT1 (0.52) | PRMT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL4476438 | 0.92 | TRPV1 (0.52) | PRMT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL4485637 | 0.91 | PRMT1 (0.50) | PRMT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL4474531 | 0.90 | PRMT1 (0.51) | PRMT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL13864936 | 0.85 | MAPT (0.46) | PRMT1MAPTRAB9ANPC1TP53 | |
| SCHEMBL4475676 | 0.82 | MAPT (0.48) | PRMT1MAPTRAB9ANPC1TP53 | |
| SCHEMBL4491823 | 0.79 | LMNA (0.51) | RAB9ANPC1KMT2ALMNA | |
| SCHEMBL4486397 | 0.76 | PFKFB3 (0.47) | PRMT1STAT3MAPTMEN1KMT2A | |
| SCHEMBL4468344 | 0.75 | MAPT (0.40) | PRMT1MAPTRAB9ANPC1TP53 | |
| SCHEMBL4479961 | 0.75 | MAPT (0.49) | MAPTTP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534804-B2 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-19 | — | — | US | claimed |
| US-20070049628-A1 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-01 | — | — | US | claimed |
| US-7534804-B2 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-19 | — | — | US | disclosed |
| US-7534804-B2 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-19 | — | — | US | disclosed |
| US-7534804-B2 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-19 | — | — | US | disclosed |
| US-20070049628-A1 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-01 | — | — | US | disclosed |
| US-20070049628-A1 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-01 | — | — | US | disclosed |
| US-20070049628-A1 | Benzoxazole inhibitors of 15-lipoxygenase | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049628-A1 | Benzoxazole inhibitors of 15-lipoxygenase | ALOX15, ALOX5, ALOX15B | PRMT1 4246/4885IL6 3399/4885STAT3 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.